Research Article
The Prognostic Effect of Serum Albumin Level on Outcomes of Hospitalized COVID-19 Patients
Table 1
Case status and demographic and clinical characteristics of patients with COVID-19, with and without in-hospital mortality.
| Variable | All patients | Patients with in-hospital mortality | Patients without in-hospital mortality | value |
| Age mean (sd), yr | 61.5 (15.3) | 65.3 (16.11) | 59.9 (15.4) | 0.006 | Male | 59.7 (14.4) | 63.1 (14.4) | 57.9 (14.2) | Female | 64 (16.2) | 70.9 (12.4) | 62.3 (16.6) |
| Sex, no./total no. (%) | Male | 178/300 (59%) | 63/87 (72%) | 115/213 (53%) | 0.003 | Female | 122/300 (41%) | 24/87 (28%) | 98/213 (46%) |
| Race, no./total no. (%) | African American | 133/300 (44%) | 37/87(43%) | 96/213(45%) | 0.687 | Hispanic | 125/300 (42%) | 36/87(41%) | 89/213 (42%) | White | 21/300 (7%) | 7/87 (8%) | 14/213 (7%) | Other | 21/300 (7%) | 7/87(8%) | 14/213 (7%) |
| BMI, mean (SD) (kg/m2) | 30.9 (7.8) | 30.5 (7.1) | 31 (8) | 0.749 | Obesity (BMI ≥30) | 140/300(47%) | 41/87 (47%) | 99/213(46%) | 0.919 | GFR (<60) | 151/300 (50%) | 59/87 (68%) | 92/213(43%) | 0.001 | AKI | 124/300 (41%) | 55/87 (63%) | 69/213 (32%) | 0.001 | DM | 125/300 (42%) | 42/87 (49%) | 83/213 (39%) | 0.138 | HTN | 190/300 (63%) | 52/87 (60%) | 138/213 (65%) | .0413 | CAD | 32/300 (11%) | 10/87 (11%) | 22/213 (10%) | 0.767 | COPD | 25/300 (6.2%) | 5/87 (6%) | 20/213 (9%) | 0.300 | AF | 15/300 (5%) | 4/87 (5%) | 11/213 (5%) | 0.838 | CHF | 37/300(12%) | 21/213 (10%) | 16/87(18%) | 0.041 | ICU admission | 99/300 (33%) | 64/87 (74%) | 35/213 (16%) | 0.001 | Albumin, mean (SD) | 2.86(0.5) | 2.6 (0.49) | 2.9(0.48) | 0.001 | CRP | 10.7 (8.3) | 8.8 (6.5) | 15.7 (10) | 0.001 | Lymphocytes | 0.95 (0.5) | 0.89 (0.5) | 0.97 (0.5) | 0.183 | D-dimer (Mic/L) | 4237 (12623) | 3120 (8835) | 7036 (188850) | 0.024 | Ferritin | 1269 (2739) | 852 (846) | 2280 (4767) | 0.001 | Lactic acid | 2.1 (1.8) | 1.9 (1.7) | 2.4 (2) | 0.046 |
|
|
BMI: body mass index, GFR: glomerular filtration rate, AKI: acute kidney injury, DM: diabetes mellitus, HTN: hypertension, CAD: coronary artery disease, COPD: chronic obstructive pulmonary disease, AF: atrial fibrillation, CHF: congestive heart failure, CRP: C-reactive protein.
|